Article
PBK is a potential therapeutic target and prognostic biomarker in ovarian cancer: integrating bioinformatics and clinical analysis
2022-03-22
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose</bold> Ovarian cancer (OC) remains the most lethal gynecological malignancy worldwide. The recrudescence and chemoresistance are main reasons for the high mortality of OC. Identifying effective therapeutic targets is an urgent need. Cancer testis antigens (CTAs) are attractive targets for cancer therapy because of their expression restriction. <bold>Methods</bold> Based on...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b0323b35-b946-599e-b0e3-4e7834d29083
- DOI
- 10.21203/rs.3.rs-961590/v1
